实时热点！百度搜索大招“AI志愿助手”上线：精准预测大学录取，助力考生圆梦

百度搜索大招“AI志愿助手”上线：精准预测大学录取，助力考生圆梦

高考落下帷幕，考生们的心绪也随着考卷的提交而忐忑不安。金榜题名固然可喜，但如何选择合适的大学和专业，却成了许多考生和家长的难题。为了帮助考生更好地进行志愿填报，百度搜索今年推出了大模型升级版高考服务，其中“AI志愿助手”功能尤为亮眼，受到了广泛关注。

大数据赋能，精准预测录取结果

“AI志愿助手”利用百度强大的AI大模型和海量高考数据，能够对考生的高考成绩进行综合分析，并结合历年录取数据、院校招生政策等因素，精准预测考生被目标院校录取的概率。考生只需输入自己的高考成绩和目标院校、专业，即可获得详细的预测结果，包括录取概率、排名区间等信息。

智能对话，提供个性化志愿方案

除了精准预测录取结果之外，“AI志愿助手”还可以提供个性化的志愿填报方案。考生可以通过自然语言与智能体进行对话，咨询有关高考政策、志愿填报细节、院校专业选择等方面的问题。智能体能够快速理解考生的需求，并结合权威数据给出准确的答案，帮助考生制定适合自身情况的志愿方案。

权威信息，助力考生了解大学

为了帮助考生更好地了解大学，百度搜索还整合了来自知名高校和专业机构的数据资源。考生可以通过百度搜索高校名称、专业或学校排名等内容，获取有关大学的基本情况、各专业就业方向及排名、薪资水平及性别比例等信息，帮助考生全面了解大学情况，做出更理智的选择。

考生点赞，称赞“AI志愿助手”实用

“AI志愿助手”的推出，受到了广大考生和家长的欢迎。许多考生表示，该功能非常实用，能够帮助他们更好地进行志愿填报。一位考生表示：“我用‘AI志愿助手’预测了一下自己被目标院校录取的概率，结果基本符合我的预期。这让我对填报志愿有了更大的信心。”

专家认为，大数据和AI技术的应用，将为高考服务带来革命性变革

高考志愿填报是一项复杂而重要的工作，传统的志愿填报方式往往耗时费力，且结果不够精准。大数据和AI技术的应用，为高考服务提供了新的思路和方法。“AI志愿助手”的上线，标志着高考服务进入了智能化时代。专家认为，随着大数据和AI技术的不断发展，未来将会有更多智能化高考服务应用落地，为考生提供更加精准、便捷的服务，助力考生圆梦大学。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.